Ana Cabranes

586 total citations
9 papers, 482 citations indexed

About

Ana Cabranes is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Ana Cabranes has authored 9 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cognitive Neuroscience. Recurrent topics in Ana Cabranes's work include Cannabis and Cannabinoid Research (9 papers), Sleep and Wakefulness Research (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Ana Cabranes is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Sleep and Wakefulness Research (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Ana Cabranes collaborates with scholars based in Spain, United Kingdom and Italy. Ana Cabranes's co-authors include Javier Fernández‐Ruíz, J.A. Ramos, Eva de Lago, Gareth Pryce, David Baker, Vincenzo Di Marzo, Antonio Garcı́a-Merino, Antonio Sánchez, Miguel Moreno‐Martet and Isabel Lastres‐Becker and has published in prestigious journals such as Brain Research, European Journal of Pharmacology and Neuropharmacology.

In The Last Decade

Ana Cabranes

9 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Cabranes Spain	8	411	260	82	62	60	9	482
Anna-Maria Szczesniak Canada	15	392 1.0×	166 0.6×	100 1.2×	50 0.8×	32 0.5×	18	503
Miguel Moreno‐Martet Spain	7	275 0.7×	157 0.6×	54 0.7×	31 0.5×	49 0.8×	7	331
Linda Console‐Bram United States	10	375 0.9×	247 0.9×	65 0.8×	16 0.3×	49 0.8×	13	563
Steven J. R. Elmes United Kingdom	10	382 0.9×	297 1.1×	78 1.0×	14 0.2×	17 0.3×	12	607
Alison J. Drysdale United Kingdom	6	360 0.9×	224 0.9×	90 1.1×	17 0.3×	78 1.3×	7	441
Francisco Espejo‐Porras Spain	12	335 0.8×	168 0.6×	56 0.7×	25 0.4×	54 0.9×	12	467
Enrico Mazzarella Italy	7	413 1.0×	182 0.7×	95 1.2×	26 0.4×	53 0.9×	8	527
Zvi Vogel Israel	9	304 0.7×	267 1.0×	57 0.7×	24 0.4×	47 0.8×	11	530
Christine Carillon France	9	621 1.5×	404 1.6×	141 1.7×	31 0.5×	61 1.0×	9	774
Kim Sun Ho United States	2	165 0.4×	263 1.0×	40 0.5×	58 0.9×	16 0.3×	3	715

Countries citing papers authored by Ana Cabranes

Since Specialization

Citations

This map shows the geographic impact of Ana Cabranes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Cabranes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Cabranes more than expected).

Fields of papers citing papers by Ana Cabranes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Cabranes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Cabranes. The network helps show where Ana Cabranes may publish in the future.

Co-authorship network of co-authors of Ana Cabranes

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Cabranes. A scholar is included among the top collaborators of Ana Cabranes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Cabranes. Ana Cabranes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Pryce, Gareth, Ana Cabranes, Javier Fernández‐Ruíz, et al.. (2013). Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. Multiple Sclerosis Journal. 19(14). 1896–1904. 29 indexed citations

Lago, Eva de, Miguel Moreno‐Martet, Ana Cabranes, J.A. Ramos, & Javier Fernández‐Ruíz. (2012). Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology. 62(7). 2299–2308. 62 indexed citations

Cabranes, Ana, Gareth Pryce, David Baker, & Javier Fernández‐Ruíz. (2006). Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice. Brain Research. 1107(1). 199–205. 27 indexed citations

Lago, Eva de, Javier Fernández‐Ruíz, Silvia Ortega‐Gutiérrez, et al.. (2005). UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. European Neuropsychopharmacology. 16(1). 7–18. 60 indexed citations

Cabranes, Ana, Kateřina Venderová, Eva de Lago, et al.. (2005). Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiology of Disease. 20(2). 207–217. 115 indexed citations

Fernández‐Ruíz, Javier, Isabel Lastres‐Becker, Ana Cabranes, Eva de Lago, & Jaime A. Ramos. (2004). Involvement of the Endocannabinoid System in Motor Disorders. 4(3). 175–182. 1 indexed citations

Lago, Eva de, Alessia Ligresti, Giorgio Ortar, et al.. (2003). In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. European Journal of Pharmacology. 484(2-3). 249–257. 83 indexed citations

Fernández‐Ruíz, Javier, Isabel Lastres‐Becker, Ana Cabranes, Sara González, & J.A. Ramos. (2002). Endocannabinoids and basal ganglia functionality. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(2-3). 257–267. 50 indexed citations

Berrendero, Fernando, Antonio Sánchez, Ana Cabranes, et al.. (2001). Changes in cannabinoid CB₁ receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse. 41(3). 195–202. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact